Noorda, Eva M <br/><br/>
Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.  [electronic resource] 

 -  Cancer  Oct 2003 
 - 1483-90 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.11648  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Chemotherapy, Cancer, Regional Perfusion--methods<br/>Cohort Studies<br/>Drug Therapy, Combination<br/>Extremities<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Limb Salvage<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Palliative Care--methods<br/>Retrospective Studies<br/>Risk Assessment<br/>Sarcoma--drug therapy<br/>Soft Tissue Neoplasms--drug therapy<br/>Survival Analysis<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--administration & dosage